Clinical Trial

JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This first-in-human, single-center study in China evaluated the safety, tolerability, and pharmacokinetics of single oral doses of JKN2306 tablets in healthy adult subjects and assessed the effect of a high-fat, high-calorie meal on the pharmacokinetics of JKN2306.
Trial Details
NCT Number NCT07412938
Lead Sponsor Joincare Pharmaceutical Group Industry Co., Ltd
Conditions Acute Pain
Enrollment 44 participants
Start Date 2025-02-12
Primary Completion 2025-07-02 (estimated)
Study Completion 2025-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-17